Stem Cell Therapy for Peripheral Arterial Disease (PAD)
Written by Dr. David Greene, MD, PhD, MBA on December 13, 2013
The US Leader in Stem Cell Therapy, Now in Mexico. Treatments start at $3750 for 25 million stem cells!
Special Promo: Get an additional 25 BILLION Exosomes IV with treatments over 50 million cells!”
The US Leader in Stem Cell Therapy, Now in Mexico. Affordable treatments start at $3750 for 25 million stem cells!
Special Promo: Get an additional 25 BILLION Exosomes IV with treatments over 50 million cells!”
Written by Dr. David Greene, MD, PhD, MBA on December 13, 2013
There are several medical conditions that result in damage in the blood vessels and arteries of the extremities. Damage in these areas can reduce the amount of blood a limb receives, lowering the amount of oxygen available to that limb for use during function. The only current options available to patients with PAD are surgical correction, with the final option of amputation if surgery is not beneficial.
There may be new hope for patients however, as regenerative treatment with stem cell therapy is showing remarkable progress in the repair and growth of new blood vessels.
Peripheral arterial disease (PAD) is the combination of these damaging conditions, which include diabetes, Buerger’s disease, and ASO. PSD results in impairment of blood and oxygen flow to the external limbs. After an extended period of time with reduced oxygen, the tissue of these areas becomes damaged.
There is currently only one advisable option available to patients with impaired flow: surgical revascularization in an attempt to return optimal blood flow to the limb. For patients who do not find success with this procedure, amputation of the limb is the last option.
Peripheral arterial disease (PAD) is the combination of these damaging conditions, which include diabetes, Buerger’s disease, and ASO. PSD results in impairment of blood and oxygen flow to the external limbs. After an extended period of time with reduced oxygen, the tissue of these areas becomes damaged.
There is currently only one advisable option available to patients with impaired flow: surgical revascularization in an attempt to return optimal blood flow to the limb. For patients who do not find success with this procedure, amputation of the limb is the last option.
As of this writing, there are two primary approaches in the treatment of PAD through stem cell therapy. The first is the direct harvesting of stem cells from the bone marrow of the patient for use in therapy. Alternatively, a hormone will be administered into the patient to stimulate bone marrow into producing excess stem cells. These will be freely released into the blood stream where they can be collected via routine blood withdrawal.
Regardless of the stem cell collection method used, the stem cells will be isolated and multiplied to increase their numbers. Once a sufficient number of cells are present, they will be transplanted back into the patient. The delivery method of these stem cells may vary, with several different methods currently under testing.
There is substantial evidence that this method of stem cell treatment is sound and that it can potentially produce the desired effect in patients with Peripheral arterial disease (PAD). The best method of collection and re-implantation are still currently under research, which a number of studies currently actively recruiting patients.
Physician First Choice offers stem cell treatments with Board Certified doctors, including treatment for peripheral artery disease. For more information and scheduling, call 888-988-0515.
Contact US
About R3 Stem Cell Mexico
Follow Us
Quick Links
Disclaimer
Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this site have been evaluated or approved by the FDA. This site does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.
Contact Us
Copyright © 2016 – 2025 R3 Stem Cell